Ketonal Forte

Ketoprofen, the active ingredient in Ketonal Forte, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It reduces pain, inflammation and swelling associated with musculoskeletal conditions and is commonly prescribed for adults experiencing acute or chronic discomfort.

GNH USA supplies Ketonal Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand through reliable logistics networks consistently.

Ketoprofen is an NSAID that alleviates pain and inflammation across several musculoskeletal and arthritic conditions. - Pain: Provides analgesic relief for acute and chronic pain states. - Inflammation: Reduces swelling and erythema in inflammatory disorders. - Osteoarthritis: Improves joint function and decreases discomfort in degenerative joint disease. - Rheumatoid arthritis: Helps control pain and inflammation associated with autoimmune joint inflammation. - Musculoskeletal injuries: Facilitates recovery by diminishing pain and swelling after trauma. - Ankylosing spondylitis: Alleviates spinal pain and stiffness.

Ketoprofen may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Skin rash: mild erythema or pruritus.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: potentially life‑threatening. - Renal impairment: acute kidney injury or worsening chronic kidney disease. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Severe hypersensitivity: anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When prescribing ketoprofen, clinicians should consider several safety precautions to minimise risk. - Renal function: assess baseline kidney function and monitor during therapy. - Gastrointestinal risk: avoid in patients with a history of ulcers or bleeding unless gastro‑protective agents are used. - Cardiovascular disease: use cautiously in patients with hypertension or heart failure. - Concomitant anticoagulants: monitor for increased bleeding tendency. - Pregnancy and lactation: evaluate risk‑benefit; avoid unless clearly needed. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Ketoprofen can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: heightened risk of ulceration and bleeding. - Lithium: may raise serum lithium levels. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may diminish renal perfusion, monitor kidney function. - ACE inhibitors or ARBs: potential for reduced renal function. - Selective serotonin reuptake inhibitors (SSRIs): increased bleeding risk. - Blood pressure medications: possible attenuation of antihypertensive effect.